upper waypoint

Federal Court Rules to Limit Access to Abortion Pill as Drug Remains Available

Save ArticleSave Article
Failed to save article

Please try again

A person's hand drops a white pill into their other hand.
A patient prepares to take the first of 2 combination pills, mifepristone, for a medication abortion during a visit to a clinic in Kansas City, Kan., on, Oct. 12, 2022. New restrictions on access to the drug used in the most common form of abortion would be imposed under a federal appeals court ruling issued Wednesday, Aug. 16, 2023, but the Supreme Court will have the final say.  (Charlie Riedel/The Associated Press)

A federal appeals court ruled Wednesday that mifepristone, one of two pills used in medication abortions, should not be prescribed past seven weeks of pregnancy or via telemedicine. However, a previous stay by the Supreme Court means this won’t go into effect right away.

The pills will remain on the market and available by telemedicine and mail for the time being.

In a 93-page ruling (PDF), the 5th Circuit Court of Appeals in New Orleans sided with plaintiffs that want to restrict use of mifepristone, a pill used in medication abortions.

The Alliance Defending Freedom, which brought the case, cheered the opinion.

“This is a significant victory for the doctors and medical associations we represent and, more importantly, the health and safety of women,” says Erin Hawley, the senior counsel with the Alliance Defending Freedom.

Sponsored

The federal Department of Justice is defending the Food and Drug Administration in the case. A spokesperson for DOJ said the department strongly disagrees with the ruling and is looking for the Supreme Court to review it.

Mary Ziegler, a professor of law at the University of California, Davis who has written books about the history of abortion, said she was not surprised by the decision. “My impression is that this is the Fifth Circuit trying to resurrect what had been a pretty flawed case in the hope that this Supreme Court is conservative enough that there’s no case too weak or extreme, really, for this court on abortion,” says Ziegler.

The Supreme Court is likely to hear the case in the fall, possibly with another case from Washington state that seeks to expand access to the medicine.

The case is an unprecedented challenge to the authority of the Food and Drug Administration to approve medications.

A three judge panel of the 5th Circuit heard arguments in the case in May. All three judges were appointed by Republicans. Two are Trump appointees, one was appointed by George W. Bush.

Mifepristone and misoprostol, the two-drug regimen, is used in about 50% of abortions now. Since its approval by the FDA in 2000, the drug has been used for abortions by more than 5 million women in the U.S. A study from KFF, an independent health policy organization, determined that medication abortion successfully terminates pregnancy 99.6% of the time. The foundation found a 0.4% risk of major complications and a mortality rate of less than 0.001%.

The crux of the plaintiffs’ case concerns those rare complications. Attorney Hawley, who is married to Sen. Josh Hawley, the Republican from Missouri, argued that physicians who oppose abortion would be facing a moral injury if they had to care for a woman after a complication after taking mifepristone.

Copyright 2023 NPR. To see more, visit https://www.npr.org.

lower waypoint
next waypoint